About us

We are a privately held biopharmaceutical company committed to bringing life-changing treatments to patients by reprogramming their own T-cells to more effectively combat cancer.

Technology

We are applying our extensive cell programming and manufacturing technology to develop a pipeline of precise, controlled and highly active engineered T-cell therapy products for the treatment of life-threatening cancers.